ES2189639A1 - Aqueous medicinal composition containing dissolved acid consists of an oral medicine containing acetyl salicylic acid dissolved in water, with additives - Google Patents
Aqueous medicinal composition containing dissolved acid consists of an oral medicine containing acetyl salicylic acid dissolved in water, with additivesInfo
- Publication number
- ES2189639A1 ES2189639A1 ES200101163A ES200101163A ES2189639A1 ES 2189639 A1 ES2189639 A1 ES 2189639A1 ES 200101163 A ES200101163 A ES 200101163A ES 200101163 A ES200101163 A ES 200101163A ES 2189639 A1 ES2189639 A1 ES 2189639A1
- Authority
- ES
- Spain
- Prior art keywords
- dissolved
- water
- additives
- medicinal composition
- oral medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001138 acetylsalicylic acid Drugs 0.000 title abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 239000000654 additive Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Aqueous compound containing acetylsalicylic acid.An aqueous compound that is easy to administer orally and that contains acetylsalicylic acid dissolved in water and, optionally, supplementary substance(s) for prevention and/or treatment of diseases.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200101163A ES2189639B1 (en) | 2001-05-22 | 2001-05-22 | AQUOUS COMPOSITION CONTAINING ACETILSALICILIC ACID. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200101163A ES2189639B1 (en) | 2001-05-22 | 2001-05-22 | AQUOUS COMPOSITION CONTAINING ACETILSALICILIC ACID. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2189639A1 true ES2189639A1 (en) | 2003-07-01 |
| ES2189639B1 ES2189639B1 (en) | 2005-02-01 |
Family
ID=8497792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200101163A Expired - Fee Related ES2189639B1 (en) | 2001-05-22 | 2001-05-22 | AQUOUS COMPOSITION CONTAINING ACETILSALICILIC ACID. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2189639B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3630120A4 (en) * | 2017-05-30 | 2021-01-13 | Rhoshan Pharmaceuticals, Inc. | STABLE, STERILE AND CRYSTALLINE O-ACETYLSALICYLIC ACID (ASPIRIN) BOTTLE DEPOSIT |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0377906A2 (en) * | 1989-01-12 | 1990-07-18 | Bayer Ag | Effervescent analgesic antacid composition having reduced sodium content |
| FR2708853A1 (en) * | 1993-06-30 | 1995-02-17 | Salsarulo Gilles | Acetylsalicylic acid composition with improved bioavailability and process for producing it |
| WO1996003980A1 (en) * | 1994-07-29 | 1996-02-15 | Bayer Corporation | Improved effervescent delivery system |
-
2001
- 2001-05-22 ES ES200101163A patent/ES2189639B1/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0377906A2 (en) * | 1989-01-12 | 1990-07-18 | Bayer Ag | Effervescent analgesic antacid composition having reduced sodium content |
| FR2708853A1 (en) * | 1993-06-30 | 1995-02-17 | Salsarulo Gilles | Acetylsalicylic acid composition with improved bioavailability and process for producing it |
| WO1996003980A1 (en) * | 1994-07-29 | 1996-02-15 | Bayer Corporation | Improved effervescent delivery system |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3630120A4 (en) * | 2017-05-30 | 2021-01-13 | Rhoshan Pharmaceuticals, Inc. | STABLE, STERILE AND CRYSTALLINE O-ACETYLSALICYLIC ACID (ASPIRIN) BOTTLE DEPOSIT |
| US10959955B1 (en) | 2017-05-30 | 2021-03-30 | Rhoshan Pharmaceuticals, Inc. | In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin) |
| US11096949B2 (en) | 2017-05-30 | 2021-08-24 | Rhoshan Pharmaceuticals, Inc. | In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid |
| US11911400B1 (en) | 2017-05-30 | 2024-02-27 | Rhoshan Pharmaceuticals, Inc. | In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid (aspirin) |
| US12048708B2 (en) | 2017-05-30 | 2024-07-30 | Rhoshan Pharmaceuticals, Inc. | In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin) |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2189639B1 (en) | 2005-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4970819A1 (en) | TREATMENT OF FEMALE SEXUAL DYSFUNCTION IN A HUMAN FEMALE | |
| ES2180646T3 (en) | ORAL LIQUID FORMULATIONS OF ALENDRONATE. | |
| FI955124A0 (en) | Mixture of veterinary medicinal products containing a proton pump inhibitor | |
| NO20062513L (en) | Compositions and dosage forms for enhanced absorption of metformin | |
| ATE339187T1 (en) | USE OF COMPOSITIONS CONTAINING ANTISEPTICS AND/OR WOUND HEALING PROMOTING ACTIVES FOR THE DEEP RESPIRATORY TRACT | |
| BR0008403A (en) | Pharmaceutical formulation for oral administration | |
| MA27093A1 (en) | SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS. | |
| ATE332147T1 (en) | ABSORPTION IMPROVERS | |
| DE69429964D1 (en) | Solid, therapeutic or hygienic, mucoadhesive composition for administration by application to the oral or nasal mucosa | |
| ATE73656T1 (en) | ANTI-INFLAMMATORY MEDICATION CONTAINING IBUPROFEN WHICH IN AQUEOUS SOLUTION HAS NO BITTER TASTE, LARYNX IRRITATION AND INTESTINAL TOXICITY. | |
| ES2087623T3 (en) | DERIVATIVES OF BENCIMIDAZOLE AS AN ANTIMICROBIAL AGENT AGAINST CAMPYLOBACTER PYLON. | |
| BR0207866A (en) | Use of flumazenil in the preparation of a drug for the treatment of cocaine addiction | |
| ATE110723T1 (en) | GASGASIC ACID INHIBITOR COMPOUNDS AND METHOD OF PREPARATION. | |
| KR920702225A (en) | Pharmaceutical composition | |
| WO2001074396A8 (en) | Composition and method for promoting oral health | |
| NO20021437D0 (en) | Procedures for the prevention of colorectal cancer | |
| ES2189639A1 (en) | Aqueous medicinal composition containing dissolved acid consists of an oral medicine containing acetyl salicylic acid dissolved in water, with additives | |
| BR9912533A (en) | Pharmaceutical composition having improved taste | |
| DK1220678T3 (en) | Pharmaceutical preparations containing copper, salicylic acid and vitamin C | |
| DE60112584D1 (en) | Process for the preparation of a liquid dosage unit and kit | |
| HUP9802005A2 (en) | Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions for reducing the cardiotoxic effect of some substances | |
| BR0313305A (en) | Analgesic agent for newborn or fetal individuals | |
| SE9700617D0 (en) | New composition | |
| ATE241974T1 (en) | PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION CONTAINING NIMELULIDE | |
| PT1242062E (en) | GEL ANIDRO UNDERSTANDING NSAID FOR TOPIC ADMINISTRATION IN ORAL CAVITY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 20030701 Kind code of ref document: A1 |
|
| FG2A | Definitive protection |
Ref document number: 2189639B1 Country of ref document: ES |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20180807 |